📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. (2014)

First Author: Hart AB

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1318810111

PubMed Identifier: 24711425

Publication URI: http://europepmc.org/abstract/MED/24711425

Type: Journal Article/Review

Volume: 111

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 16

ISSN: 0027-8424